Zivo Bioscience annual gross margin
2023
2024
Zivo Bioscience Gross Margin Growth & History (ZIVO)
Zivo Bioscience's gross margin was 31.14% for fiscal 2024.
View full Zivo Bioscience company overviewZivo Bioscience annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | 31.14% | −10.85 pp |
| 2023 | 2023-12-31 | 41.99% | — |
Zivo Bioscience quarterly gross margin
Q2.23
Q3.23
Q4.23
Q1.24
Q3.24
Q4.24
Q2.25
Q3.25
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q3 2025 | 2025-09-30 | 32.44% | −2.56 pp |
| Q2 2025 | 2025-06-30 | 33.56% | −1.45 pp |
| Q4 2024 | 2024-12-31 | 30.00% | −5.00 pp |
| Q3 2024 | 2024-09-30 | 30.00% | −52.69 pp |
| Q1 2024 | 2024-03-31 | 35.00% | — |
| Q4 2023 | 2023-12-31 | 35.01% | — |
| Q3 2023 | 2023-09-30 | 35.00% | — |
| Q2 2023 | 2023-06-30 | 82.69% | — |
Zivo Bioscience gross margin trends
Across the available reported history, Zivo Bioscience's gross margin decreased from 41.99% to 31.14%, a change of −10.85 percentage points. The latest reported quarter, Q3 2025, shows 32.44%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Zivo Bioscience filings at SEC.gov ↗